Methods of international health technology assessment agencies for economic evaluations- a comparative analysis

被引:55
作者
Mathes, Tim [1 ]
Jacobs, Esther [1 ]
Morfeld, Jana-Carina [1 ]
Pieper, Dawid [1 ]
机构
[1] Univ Witten Herdecke, Fac Hlth, Sch Med, Inst Res Operat Med, D-51109 Cologne, Germany
来源
BMC HEALTH SERVICES RESEARCH | 2013年 / 13卷
关键词
COST-EFFECTIVENESS; DECISION-MAKING; ASSESSMENT ORGANIZATIONS; KEY PRINCIPLES; GUIDELINES; CARE; GENERALIZABILITY; UNCERTAINTY;
D O I
10.1186/1472-6963-13-371
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The number of Health Technology Assessment (HTA) agencies increases. One component of HTAs are economic aspects. To incorporate economic aspects commonly economic evaluations are performed. A convergence of recommendations for methods of health economic evaluations between international HTA agencies would facilitate the adaption of results to different settings and avoid unnecessary expense. A first step in this direction is a detailed analysis of existing similarities and differences in recommendations to identify potential for harmonization. The objective is to provide an overview and comparison of the methodological recommendations of international HTA agencies for economic evaluations. Methods: The webpages of 127 international HTA agencies were searched for guidelines containing recommendations on methods for the preparation of economic evaluations. Additionally, the HTA agencies were requested information on methods for economic evaluations. Recommendations of the included guidelines were extracted in standardized tables according to 13 methodological aspects. All process steps were performed independently by two reviewers. Results: Finally 25 publications of 14 HTA agencies were included in the analysis. Methods for economic evaluations vary widely. The greatest accordance could be found for the type of analysis and comparator. Cost-utility-analyses or cost-effectiveness-analyses are recommended. The comparator should continuously be usual care. Again the greatest differences were shown in the recommendations on the measurement/sources of effects, discounting and in the analysis of sensitivity. The main difference regarding effects is the focus either on efficacy or effectiveness. Recommended discounting rates range from 1.5% - 5% for effects and 3% - 5% for costs whereby it is mostly recommended to use the same rate for costs and effects. With respect to the analysis of sensitivity the main difference is that oftentimes the probabilistic or deterministic approach is recommended exclusively. Methods for modeling are only described vaguely and mainly with the rational that the "appropriate model" depends on the decision problem. Considering all other aspects a comparison is challenging as recommendations vary regarding detailedness and addressed issues. Conclusion: There is a considerable unexplainable variance in recommendations. Further effort is needed to harmonize methods for preparing economic evaluations.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Health Technology Assessment and Economic Evaluation across Jurisdictions [J].
Simoens, Steven .
VALUE IN HEALTH, 2010, 13 (06) :857-859
[42]   Health Technology Assessment: conceptual framework and international perspective [J].
Kuhn-Barrientos, Lucy .
REVISTA MEDICA DE CHILE, 2014, 142 (01) :S11-S15
[43]   Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis [J].
Hollingworth, Samantha ;
Fenny, Ama Pokuaa ;
Yu, Su-Yeon ;
Ruiz, Francis ;
Chalkidou, Kalipso .
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
[44]   Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines [J].
Ewa Orlewska ;
Piotr Mierzejewski .
The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4) :296-303
[45]   HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES [J].
Ciani, Oriana ;
Wilcher, Britni ;
Blankart, Carl Rudolf ;
Hatz, Maximilian ;
Rupel, Valentina Prevolnik ;
Erker, Renata Slabe ;
Varabyova, Yauheniya ;
Taylor, Rod S. .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2015, 31 (03) :154-165
[46]   Health Technology Assessment of Public Health Interventions Published 2012 to 2016: An Analysis of Characteristics and Comparison of Methods [J].
Polus, Stephanie ;
Mathes, Tim ;
Klingler, Corinna ;
Messer, Melanie ;
Gerhardus, Ansgar ;
Stegbauer, Constance ;
Willms, Gerald ;
Ehrenreich, Heidi ;
Marckmann, Georg ;
Pieper, Dawid .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) :280-290
[47]   Digital Health Technology Interventions for Improving Medication Safety: Systematic Review of Economic Evaluations [J].
Insani, Widya Norma ;
Zakiyah, Neily ;
Puspitasari, Irma Melyani ;
Permana, Muhammad Yorga ;
Parmikanti, Kankan ;
Rusyaman, Endang ;
Suwantika, Auliya Abdurrohim .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2025, 27
[48]   The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada [J].
Hong, Jihyung ;
Bae, Eun-Young ;
Cha, Sohee ;
Lee, Joohyun .
BMC HEALTH SERVICES RESEARCH, 2025, 25 (01)
[49]   Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature [J].
Helter, Timea Mariann ;
Coast, Joanna ;
Laszewska, Agata ;
Stamm, Tanja ;
Simon, Judit .
QUALITY OF LIFE RESEARCH, 2020, 29 (06) :1433-1464
[50]   Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis [J].
Catala-Lopez, Ferran ;
Caulley, Lisa ;
Ridao, Manuel ;
Hutton, Brian ;
Husereau, Don ;
Drummond, Michael F. ;
Alonso-Arroyo, Adolfo ;
Pardo-Fernandez, Manuel ;
Bernal-Delgado, Enrique ;
Meneu, Ricard ;
Tabares-Seisdedos, Rafael ;
Ramon Repullo, Jose ;
Moher, David .
BMJ OPEN, 2020, 10 (02)